Compare Ford Motor Company (F) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ford Motor Company vs Repligen Corporation Common Stock — how do they compare? Ford Motor Company trades at $12.07 (market cap $48.25B), while Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B). The key difference: Ford Motor Company is far larger — about 4.3× Repligen Corporation Common Stock's market cap, and Ford Motor Company pays a 4.96% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ford Motor Company for 105 Days and Repligen Corporation Common Stock for 0 Days on average.
| F | RGEN | |
|---|---|---|
Market Cap | $48.25B | $11.14B |
Volume | 33,627,673 | 1,259,263 |
Sector | Consumer Cyclical | Health |
52-Week High | $17.44 | $194.57 |
52-Week Low | $11.21 | $102.87 |
Typical Hold Time | 105 Days | 0 Days |
Enterprise Value | $180.21B | $11.02B |
Dividend Yield | 4.96% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ford Motor Company (F) trades at $12.10, up 0.83% with bearish technical indicators. The company reported mixed Q2 2026 earnings, beating expectations but showing negative profitability metrics including -3.93% net income margin. Recent news highlights sales declines and production challenges, though the company maintains strong cash flow from operations of $21.28 billion in 2025.
Ford faces headwinds from declining sales and profitability challenges, offset by strong commercial division performance and positive analyst sentiment with a $15.79 price target. Key risks include competitive pressure from Asian automakers and ongoing production disruptions, while the current valuation appears attractive with P/E of 11.21 and P/S of 0.26.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ford Motor Company
Ford Motor Company designs, manufactures, and services cars and trucks. The Company also provides vehicle-related financing, leasing, and insurance through its subsidiary.
Read more on F →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
